Cuba submits to WHO for approval of COVID-19 vaccine Abdala

Specifically, on April 2, Biotechnology and Pharmaceutical Corporation BioCubaFarma said that the Center for Genetic Engineering and Biotechnology (CIGB) of this corporation has officially talked with the World Health Organization (WHO) to start the assessment process. Abdala vaccine prevent COVID-19. Abdala vaccine is manufactured by BioCubaFarma Biotechnology and Pharmaceutical Corporation of Cuba.

BioCubaFarma emphasized, the profile of the Cuban-researched and developed Abdala vaccine is ready for review by experts. Up to now, more than 8 million Cubans have been vaccinated against COVID-19 with the Abdala vaccine. Vaccines against COVID-19 of Cuba have also been exported to Venezuela, Nicaragua, Iran, Mexico and Vietnam.

Via Twitter, BioCubaFarma announced that Finlay Vaccine Institute and CIGB are working with Cuba’s Center for State Control of Drugs, Equipment and Medical Supplies (CECMED) to present the research results soon. clinical trials of two other COVID-19 vaccine candidates, Soberana 01 and Mambisa.

Abdala vaccine is manufactured by BioCubaFarma Biotechnology and Pharmaceutical Corporation of Cuba. (Photo: Deutsche Welle)

Cuba has completed vaccination against COVID-19 for nearly 90% of the population, including children aged 2 years and older, with domestic vaccines, and deployed the 4th injection to more than 6.2 million people. out of a total population of 11.2 million. Cuba is also considered very successful in treating patients with COVID-19 with a cure rate of more than 99% to date.

Cuba’s COVID-19 vaccine requires 3 shots, but these protein vaccines are stable at 2 – 8°C, so they don’t require additional costs for specialized refrigeration equipment. Therefore, the use of this vaccine in low-income countries will be easier than with mRNA vaccines that need to be stored in a deep freezer.

According to Cuban scientists, vaccines developed by the country such as Abdala, Soberana 02 and Soberana Plus provide more than 90% protection against symptomatic COVID-19 when the subject has been vaccinated. 3 doses according to the correct schedule.

However, because Cuba has not yet published the results of its large-scale clinical trials in peer-reviewed journals, nor has it submitted documents required by the World Health Organization (WHO) for the The above vaccine is approved, some foreign medical experts are still waiting for the WHO decision.

Cuba is considered a bright spot in Latin America’s vaccine in the context that this region is still the epicenter of the global COVID-19 pandemic. This is the only Latin American country that produces its own vaccine against COVID-19.

* Invite readers to watch programs broadcast by Vietnam Television on TV Online and VTVGo!